Real-Time Imaging of Ammonia Release from Single Live Cells via Liquid Crystal Droplets Immobilized on the Cell Membrane.
Mashooq KhanWeiwei LiSifeng MaoSyed Niaz Ali ShahJin-Ming LinPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2019)
Tumor cells exhibit prominent metabolic alterations through which they acclimatize to their stressful microenvironment. These cells have a high rate of glutaminolysis and release ammonia (NH3) as a byproduct, which may function as a diffusible signal among cancer cells and can reveal cellular heterogeneity. E7, a nematic liquid crystal (LC), is doped with 4-pentyl-4'-biphenyl carboxylic acid (PBA) and encapsulated in polymeric microcapsules (P-E7PBA), which are then immobilized on cells in a microfluidic channel. Normal human umbilical vein endothelial cells (HUVECs) and myeloma, human primary glioblastoma (U87), human colon carcinoma (Caco-2), and human breast adenocarcinoma (MCF-7) cells are investigated for the release of NH3. The P-E7PBA is able to visualize NH3 release from the cell via a radial-to-bipolar (R-B) orientation change, observed through a polarized optical microscope. The various cell lines significantly differ in their response time required for an R-B change. The mean response times for Caco-2, U87, and MCF-7 cells are 277, 155, and 121 s, respectively. NH3 release from a single cell captured in a microwell flow chip shows a similar R-B change. The P-E7PBA droplets technology could be applied to other multiple targets by functionalizing LCs with different probes.
Keyphrases
- endothelial cells
- induced apoptosis
- single cell
- cell cycle arrest
- stem cells
- room temperature
- oxidative stress
- endoplasmic reticulum stress
- squamous cell carcinoma
- high resolution
- rna seq
- signaling pathway
- drug delivery
- cell proliferation
- genome wide
- dna methylation
- gene expression
- quantum dots
- breast cancer cells
- photodynamic therapy
- mass spectrometry
- radiation therapy
- ionic liquid
- anaerobic digestion
- single molecule
- rectal cancer
- drug release
- fluorescent probe
- high speed